Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A changed proof marketed as an different to a mammogram for tit cancer detection is not an productive screening TOOL, US health officials say. With the nipple aspirate test, a soul interrogate collects fluid from a woman's nipple. The formless is then examined for jargon exceptional and potentially cancerous cells capsules. The check-up is advertised as easier, more comfortable and less painful than mammograms.

However, there is no trial to support claims that the test can sense breast cancer, said Dr David Lerner, a medical lawman at the US Food and Drug Administration and a heart imaging specialist growth hormone deficiency. "FDA's apply to is that the nipple aspirate check is being touted as a standalone tool to screen for and pinpoint breast cancer as an alternative to mammography," Lerner said in an intercession news release.

So "Our unease is that women will forgo a mammogram and have this assay instead". Skipping a mammogram could put a woman's form and life at risk if breast cancer goes undetected, Lerner warned web site. He said there is no precise prove that the nipple aspirate test, when utilized on its own, is an effective screening tool for heart of hearts cancer or any other medical condition.

The test is still being forced to determine if it might be useful in combination with other methods to concealment for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of core cancer. Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate assess - called the ForeCYTE Breast Health Test - off the retail after being warned by the FDA that its claims about the exam were unsubstantiated. The enterprise claimed the evaluation was "literally a Pap daub for bust cancer". Pap smears are a gauge try for cervical cancer.

And Women who have had a nipple aspirate trial as a form of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should powwow to their medicate about whether additional tests are needed, the FDA said. One in eight US women will manifest knocker cancer in her lifetime medicine. The malady is the second best cancer killer of women in the country.